Obinutuzumab
| Obinutuzumab | |
|---|---|
| Term | Obinutuzumab |
| Short definition | Obatoclax mesylate - (pronounced) (oh-BA-toh-klax MEH-zih-layt) A substance being studied to treat various types of cancer. It is a form of obatoclax that blocks the activity of certain proteins needed for cells to live and can cause tumor cells to die. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
obinutuzumab - (pronounced) (OH-bin-yoo-TOO-zoo-mab) A medicine used with other medicines to treat certain types of follicular lymphoma and chronic lymphocytic leukaemia. It is also being studied in the treatment of other types of cancer. Obinutuzumab attaches to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of leukemia and lymphoma cells. Obinutuzumab can block CD20 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called Gazyva
External links
- Medical encyclopedia article on Obinutuzumab
- Wikipedia's article - Obinutuzumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski